25 XP   0   0   10

Chongqing Pharscin Pharmaceutical Co Ltd
Buy, Hold or Sell?

Let's analyse Pharscin together

PenkeI guess you are interested in Chongqing Pharscin Pharmaceutical Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Chongqing Pharscin Pharmaceutical Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Chongqing Pharscin Pharmaceutical Co Ltd

I send you an email if I find something interesting about Chongqing Pharscin Pharmaceutical Co Ltd.

Quick analysis of Pharscin (30 sec.)










What can you expect buying and holding a share of Pharscin? (30 sec.)

How much money do you get?

How much money do you get?
¥0.02
When do you have the money?
1 year
How often do you get paid?
95.0%

What is your share worth?

Current worth
¥3.87
Expected worth in 1 year
¥3.89
How sure are you?
95.0%

+ What do you gain per year?

Total Gains per Share
¥0.16
Return On Investment
1.1%

For what price can you sell your share?

Current Price per Share
¥14.44
Expected price per share
¥9.82 - ¥17.43
How sure are you?
50%

1. Valuation of Pharscin (5 min.)




Live pricePrice per Share (EOD)

¥14.44

Intrinsic Value Per Share

¥1.90 - ¥2.26

Total Value Per Share

¥5.78 - ¥6.13

2. Growth of Pharscin (5 min.)




Is Pharscin growing?

Current yearPrevious yearGrowGrow %
How rich?$223.2m$190.5m$34.1m15.2%

How much money is Pharscin making?

Current yearPrevious yearGrowGrow %
Making money$1.1m$3.3m-$2.2m-200.9%
Net Profit Margin4.5%12.6%--

How much money comes from the company's main activities?

3. Financial Health of Pharscin (5 min.)




What can you expect buying and holding a share of Pharscin? (5 min.)

Welcome investor! Pharscin's management wants to use your money to grow the business. In return you get a share of Pharscin.

What can you expect buying and holding a share of Pharscin?

First you should know what it really means to hold a share of Pharscin. And how you can make/lose money.

Speculation

The Price per Share of Pharscin is ¥14.44. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Pharscin.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Pharscin, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥3.87. Based on the TTM, the Book Value Change Per Share is ¥0.00 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.21 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.04 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Pharscin.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.000.0%0.000.0%0.010.0%0.010.1%0.010.1%
Usd Book Value Change Per Share0.000.0%0.000.0%0.030.2%0.030.2%0.030.2%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.000.0%0.010.0%0.030.2%0.030.2%0.030.2%
Usd Price Per Share2.13-2.28-2.16-2.24-2.24-
Price to Earnings Ratio-133.57-176.92-93.01-123.02-123.02-
Price-to-Total Gains Ratio-502.73-454.07-375.93-521.74-521.74-
Price to Book Ratio3.99-4.23-4.71-5.53-5.53-
Price-to-Total Gains Ratio-502.73-454.07-375.93-521.74-521.74-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.99272
Number of shares501
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.03
Usd Total Gains Per Share0.010.03
Gains per Quarter (501 shares)2.7814.79
Gains per Year (501 shares)11.1459.17
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1101165449
22021211107108
33042317161167
44053422214226
54964528268285
65975634321344
76996739375403
879107845429462
989118950482521
10991210056536580

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share3.01.00.075.0%11.01.00.091.7%19.01.00.095.0%19.01.00.095.0%19.01.00.095.0%
Book Value Change Per Share2.02.00.050.0%9.03.00.075.0%17.03.00.085.0%17.03.00.085.0%17.03.00.085.0%
Dividend per Share3.00.01.075.0%11.00.01.091.7%19.00.01.095.0%19.00.01.095.0%19.00.01.095.0%
Total Gains per Share3.01.00.075.0%11.01.00.091.7%19.01.00.095.0%19.01.00.095.0%19.01.00.095.0%

Fundamentals of Pharscin

About Chongqing Pharscin Pharmaceutical Co Ltd

Chongqing Pharscin Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of drugs in China. The company offers tablets, powders, granules, soft capsules, powder injections, freeze-dried powders, injections, chemical raw materials, and small volume injections. It provides its products for the treatment of CNS, digestion, otolaryngology, oncology, cardiovascular, and cerebrovascular related diseases. The company was founded in 1996 and is headquartered in Chongqing, China.

Fundamental data was last updated by Penke on 2024-04-23 05:54:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is inefficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is just able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is cheap.

1.1. Profitability of Chongqing Pharscin Pharmaceutical Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Pharscin earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Pharscin to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -6.9% means that ¥-0.07 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Chongqing Pharscin Pharmaceutical Co Ltd:

  • The MRQ is -6.9%. The company is making a loss. -1
  • The TTM is 4.5%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ-6.9%TTM4.5%-11.3%
TTM4.5%YOY12.6%-8.1%
TTM4.5%5Y12.3%-7.9%
5Y12.3%10Y12.3%0.0%
1.1.2. Return on Assets

Shows how efficient Pharscin is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Pharscin to the Drug Manufacturers - Specialty & Generic industry mean.
  • -0.7% Return on Assets means that Pharscin generated ¥-0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Chongqing Pharscin Pharmaceutical Co Ltd:

  • The MRQ is -0.7%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is 0.4%. Using its assets, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ-0.7%TTM0.4%-1.1%
TTM0.4%YOY1.3%-0.9%
TTM0.4%5Y1.6%-1.1%
5Y1.6%10Y1.6%0.0%
1.1.3. Return on Equity

Shows how efficient Pharscin is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Pharscin to the Drug Manufacturers - Specialty & Generic industry mean.
  • -0.7% Return on Equity means Pharscin generated ¥-0.01 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Chongqing Pharscin Pharmaceutical Co Ltd:

  • The MRQ is -0.7%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is 0.5%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ-0.7%TTM0.5%-1.2%
TTM0.5%YOY1.8%-1.3%
TTM0.5%5Y2.2%-1.7%
5Y2.2%10Y2.2%0.0%

1.2. Operating Efficiency of Chongqing Pharscin Pharmaceutical Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Pharscin is operating .

  • Measures how much profit Pharscin makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Pharscin to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Chongqing Pharscin Pharmaceutical Co Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM5.9%-5.9%
TTM5.9%YOY10.4%-4.5%
TTM5.9%5Y13.1%-7.2%
5Y13.1%10Y13.1%0.0%
1.2.2. Operating Ratio

Measures how efficient Pharscin is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.55 means that the operating costs are ¥1.55 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Chongqing Pharscin Pharmaceutical Co Ltd:

  • The MRQ is 1.552. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.394. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.552TTM1.394+0.158
TTM1.394YOY1.253+0.141
TTM1.3945Y1.294+0.100
5Y1.29410Y1.2940.000

1.3. Liquidity of Chongqing Pharscin Pharmaceutical Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Pharscin is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 4.74 means the company has ¥4.74 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Chongqing Pharscin Pharmaceutical Co Ltd:

  • The MRQ is 4.742. The company is very able to pay all its short-term debts. +2
  • The TTM is 4.413. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ4.742TTM4.413+0.329
TTM4.413YOY4.559-0.145
TTM4.4135Y3.818+0.595
5Y3.81810Y3.8180.000
1.3.2. Quick Ratio

Measures if Pharscin is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Pharscin to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.90 means the company can pay off ¥0.90 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Chongqing Pharscin Pharmaceutical Co Ltd:

  • The MRQ is 0.898. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 1.055. The company is just able to pay all its short-term debts with the most liquid assets.
Trends
Current periodCompared to+/- 
MRQ0.898TTM1.055-0.157
TTM1.055YOY1.530-0.475
TTM1.0555Y1.331-0.276
5Y1.33110Y1.3310.000

1.4. Solvency of Chongqing Pharscin Pharmaceutical Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Pharscin assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Pharscin to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.13 means that Pharscin assets are financed with 12.6% credit (debt) and the remaining percentage (100% - 12.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Chongqing Pharscin Pharmaceutical Co Ltd:

  • The MRQ is 0.126. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.138. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.126TTM0.138-0.012
TTM0.138YOY0.244-0.106
TTM0.1385Y0.264-0.126
5Y0.26410Y0.2640.000
1.4.2. Debt to Equity Ratio

Measures if Pharscin is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Pharscin to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 14.4% means that company has ¥0.14 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Chongqing Pharscin Pharmaceutical Co Ltd:

  • The MRQ is 0.144. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.160. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.144TTM0.160-0.016
TTM0.160YOY0.331-0.171
TTM0.1605Y0.373-0.213
5Y0.37310Y0.3730.000

2. Market Valuation of Chongqing Pharscin Pharmaceutical Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Pharscin generates.

  • Above 15 is considered overpriced but always compare Pharscin to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -133.57 means the investor is paying ¥-133.57 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Chongqing Pharscin Pharmaceutical Co Ltd:

  • The EOD is -124.838. Based on the earnings, the company is expensive. -2
  • The MRQ is -133.569. Based on the earnings, the company is expensive. -2
  • The TTM is 176.918. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-124.838MRQ-133.569+8.732
MRQ-133.569TTM176.918-310.487
TTM176.918YOY93.012+83.906
TTM176.9185Y123.015+53.903
5Y123.01510Y123.0150.000
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Chongqing Pharscin Pharmaceutical Co Ltd:

  • The EOD is 44.047. Based on how much money comes from the company's main activities, the company is fair priced.
  • The MRQ is 47.127. Based on how much money comes from the company's main activities, the company is fair priced.
  • The TTM is 4.803. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD44.047MRQ47.127-3.081
MRQ47.127TTM4.803+42.324
TTM4.803YOY71.888-67.085
TTM4.8035Y163.940-159.138
5Y163.94010Y163.9400.000
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Pharscin is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Chongqing Pharscin Pharmaceutical Co Ltd:

  • The EOD is 3.727. Based on the equity, the company is fair priced.
  • The MRQ is 3.988. Based on the equity, the company is fair priced.
  • The TTM is 4.227. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD3.727MRQ3.988-0.261
MRQ3.988TTM4.227-0.239
TTM4.227YOY4.712-0.485
TTM4.2275Y5.529-1.302
5Y5.52910Y5.5290.000
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Chongqing Pharscin Pharmaceutical Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.0310.005-782%0.206-115%0.194-116%0.194-116%
Book Value Per Share--3.8743.899-1%3.306+17%3.057+27%3.057+27%
Current Ratio--4.7424.413+7%4.559+4%3.818+24%3.818+24%
Debt To Asset Ratio--0.1260.138-8%0.244-48%0.264-52%0.264-52%
Debt To Equity Ratio--0.1440.160-10%0.331-56%0.373-61%0.373-61%
Dividend Per Share---0.036-100%0.033-100%0.020-100%0.020-100%
Eps---0.0290.008-449%0.050-157%0.057-150%0.057-150%
Free Cash Flow Per Share--0.0820.076+8%-0.028+135%0.021+295%0.021+295%
Free Cash Flow To Equity Per Share--0.082-0.002+102%-0.064+179%-0.006+107%-0.006+107%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--2.257--------
Intrinsic Value_10Y_min--1.904--------
Intrinsic Value_1Y_max--0.105--------
Intrinsic Value_1Y_min--0.103--------
Intrinsic Value_3Y_max--0.407--------
Intrinsic Value_3Y_min--0.387--------
Intrinsic Value_5Y_max--0.821--------
Intrinsic Value_5Y_min--0.754--------
Market Cap6030086240.000-7%6451863051.3006885119227.075-6%6545818898.260-1%6771738091.067-5%6771738091.067-5%
Net Profit Margin---0.0690.045-253%0.126-154%0.123-156%0.123-156%
Operating Margin---0.059-100%0.104-100%0.131-100%0.131-100%
Operating Ratio--1.5521.394+11%1.253+24%1.294+20%1.294+20%
Pb Ratio3.727-7%3.9884.227-6%4.712-15%5.529-28%5.529-28%
Pe Ratio-124.838+7%-133.569176.918-175%93.012-244%123.015-209%123.015-209%
Price Per Share14.440-7%15.45016.488-6%15.675-1%16.216-5%16.216-5%
Price To Free Cash Flow Ratio44.047-7%47.1274.803+881%71.888-34%163.940-71%163.940-71%
Price To Total Gains Ratio-469.862+7%-502.726454.072-211%375.934-234%521.744-196%521.744-196%
Quick Ratio--0.8981.055-15%1.530-41%1.331-33%1.331-33%
Return On Assets---0.0070.004-256%0.013-148%0.016-142%0.016-142%
Return On Equity---0.0070.005-250%0.018-142%0.022-134%0.022-134%
Total Gains Per Share---0.0310.040-176%0.240-113%0.214-114%0.214-114%
Usd Book Value--223273099.025224719163.930-1%190527591.150+17%176170623.408+27%176170623.408+27%
Usd Book Value Change Per Share---0.0040.001-782%0.028-115%0.027-116%0.027-116%
Usd Book Value Per Share--0.5350.538-1%0.456+17%0.422+27%0.422+27%
Usd Dividend Per Share---0.005-100%0.005-100%0.003-100%0.003-100%
Usd Eps---0.0040.001-449%0.007-157%0.008-150%0.008-150%
Usd Free Cash Flow--4723134.1924365060.739+8%-1641320.166+135%1196199.325+295%1196199.325+295%
Usd Free Cash Flow Per Share--0.0110.010+8%-0.004+135%0.003+295%0.003+295%
Usd Free Cash Flow To Equity Per Share--0.0110.000+102%-0.009+179%-0.001+107%-0.001+107%
Usd Market Cap832151901.120-7%890357101.079950146453.336-6%903323007.960-1%934499856.567-5%934499856.567-5%
Usd Price Per Share1.993-7%2.1322.275-6%2.163-1%2.238-5%2.238-5%
Usd Profit---1666468.2041128120.683-248%3394821.937-149%3531512.644-147%3531512.644-147%
Usd Revenue--24327362.96823858226.375+2%27088807.069-10%27927096.051-13%27927096.051-13%
Usd Total Gains Per Share---0.0040.006-176%0.033-113%0.030-114%0.030-114%
 EOD+4 -4MRQTTM+12 -23YOY+15 -205Y+15 -2010Y+15 -20

3.2. Fundamental Score

Let's check the fundamental score of Chongqing Pharscin Pharmaceutical Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-124.838
Price to Book Ratio (EOD)Between0-13.727
Net Profit Margin (MRQ)Greater than0-0.069
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.898
Current Ratio (MRQ)Greater than14.742
Debt to Asset Ratio (MRQ)Less than10.126
Debt to Equity Ratio (MRQ)Less than10.144
Return on Equity (MRQ)Greater than0.15-0.007
Return on Assets (MRQ)Greater than0.05-0.007
Total3/10 (30.0%)

3.3. Technical Score

Let's check the technical score of Chongqing Pharscin Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5059.762
Ma 20Greater thanMa 5013.504
Ma 50Greater thanMa 10013.919
Ma 100Greater thanMa 20014.510
OpenGreater thanClose14.240
Total1/5 (20.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Income before Tax  26,2579,51935,776-24,35111,425-7,1104,315-13,034-8,719
Net Income  25,5544,54730,101-18,83911,262-7,8493,413-15,489-12,076
Operating Income  24,3829,80734,189-24,6509,539-3,4456,094-14,777-8,683
Net Income from Continuing Operations  25,5544,54730,101-18,83911,262-7,8493,413-15,489-12,076



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets1,851,454
Total Liabilities233,533
Total Stockholder Equity1,617,921
 As reported
Total Liabilities 233,533
Total Stockholder Equity+ 1,617,921
Total Assets = 1,851,454

Assets

Total Assets1,851,454
Total Current Assets894,639
Long-term Assets956,815
Total Current Assets
Cash And Cash Equivalents 437,565
Net Receivables 169,364
Inventory 151,677
Other Current Assets 50,207
Total Current Assets  (as reported)894,639
Total Current Assets  (calculated)808,812
+/- 85,827
Long-term Assets
Property Plant Equipment 593,415
Intangible Assets 158,941
Long-term Assets Other 10,078
Long-term Assets  (as reported)956,815
Long-term Assets  (calculated)762,434
+/- 194,381

Liabilities & Shareholders' Equity

Total Current Liabilities188,677
Long-term Liabilities44,856
Total Stockholder Equity1,617,921
Total Current Liabilities
Accounts payable 55,233
Other Current Liabilities 1,836
Total Current Liabilities  (as reported)188,677
Total Current Liabilities  (calculated)57,068
+/- 131,609
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt140
Long-term Liabilities  (as reported)44,856
Long-term Liabilities  (calculated)140
+/- 44,716
Total Stockholder Equity
Retained Earnings 648,691
Total Stockholder Equity (as reported)1,617,921
Total Stockholder Equity (calculated)648,691
+/- 969,230
Other
Capital Stock417,596
Common Stock Shares Outstanding 417,596
Net Invested Capital 1,617,921
Net Working Capital 705,962
Property Plant and Equipment Gross 593,415



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-31
> Total Assets 
1,130,168
1,454,398
1,570,577
1,637,470
1,641,062
1,709,458
1,716,397
1,721,413
1,753,553
1,813,212
1,768,507
1,771,484
1,791,637
1,822,584
1,814,895
1,866,667
1,937,719
1,921,628
1,845,694
1,851,454
1,851,4541,845,6941,921,6281,937,7191,866,6671,814,8951,822,5841,791,6371,771,4841,768,5071,813,2121,753,5531,721,4131,716,3971,709,4581,641,0621,637,4701,570,5771,454,3981,130,168
   > Total Current Assets 
557,536
830,295
882,135
871,501
900,030
918,780
897,101
889,011
933,778
986,398
919,122
894,098
899,949
916,791
920,687
956,949
1,015,549
944,843
872,860
894,639
894,639872,860944,8431,015,549956,949920,687916,791899,949894,098919,122986,398933,778889,011897,101918,780900,030871,501882,135830,295557,536
       Cash And Cash Equivalents 
34,886
350,257
278,118
286,796
295,476
395,171
508,942
481,405
473,438
522,995
465,232
429,968
472,531
433,544
422,040
503,529
547,123
508,524
453,534
437,565
437,565453,534508,524547,123503,529422,040433,544472,531429,968465,232522,995473,438481,405508,942395,171295,476286,796278,118350,25734,886
       Short-term Investments 
0
92,491
193,557
193,245
193,735
143,253
0
50,068
60,506
10,000
50,131
80,608
45,535
81,153
81,860
0
0
0
0
0
0000081,86081,15345,53580,60850,13110,00060,50650,0680143,253193,735193,245193,55792,4910
       Net Receivables 
229,784
239,763
243,660
300,620
315,685
268,955
282,531
230,274
267,657
302,412
271,449
242,834
256,845
264,410
286,914
216,844
211,736
264,529
242,641
169,364
169,364242,641264,529211,736216,844286,914264,410256,845242,834271,449302,412267,657230,274282,531268,955315,685300,620243,660239,763229,784
       Inventory 
67,773
64,648
77,158
86,395
88,161
99,431
100,778
118,567
119,364
139,196
125,537
127,437
117,612
124,695
122,559
114,756
150,376
153,087
163,297
151,677
151,677163,297153,087150,376114,756122,559124,695117,612127,437125,537139,196119,364118,567100,77899,43188,16186,39577,15864,64867,773
       Other Current Assets 
152,227
2,767
40
4,444
6,973
11,969
4,850
8,660
12,813
11,794
6,772
13,252
7,427
12,991
7,314
67
1,960
18,703
13,388
50,207
50,20713,38818,7031,960677,31412,9917,42713,2526,77211,79412,8138,6604,85011,9696,9734,444402,767152,227
   > Long-term Assets 
572,632
624,102
688,442
765,969
741,032
790,678
819,296
832,402
819,775
826,814
849,386
877,386
891,688
905,793
894,208
909,717
922,170
976,784
972,834
956,815
956,815972,834976,784922,170909,717894,208905,793891,688877,386849,386826,814819,775832,402819,296790,678741,032765,969688,442624,102572,632
       Property Plant Equipment 
379,724
434,887
542,264
629,046
593,445
635,979
659,134
673,615
663,810
652,538
650,628
654,212
645,852
645,324
635,753
621,942
612,033
674,336
605,790
593,415
593,415605,790674,336612,033621,942635,753645,324645,852654,212650,628652,538663,810673,615659,134635,979593,445629,046542,264434,887379,724
       Intangible Assets 
74,300
53,920
77,762
77,634
76,296
76,072
74,414
73,655
73,037
75,123
79,130
99,720
99,778
106,308
106,353
115,220
145,061
150,734
157,659
158,941
158,941157,659150,734145,061115,220106,353106,30899,77899,72079,13075,12373,03773,65574,41476,07276,29677,63477,76253,92074,300
       Other Assets 
126,609
124,643
83,561
61,120
73,644
82,615
68,753
68,390
67,978
89,228
93,769
89,329
102,572
98,263
99,744
0
112,158
98,288
158,714
0
0158,71498,288112,158099,74498,263102,57289,32993,76989,22867,97868,39068,75382,61573,64461,12083,561124,643126,609
> Total Liabilities 
270,022
464,991
534,587
566,669
540,688
590,233
559,707
539,592
534,237
584,540
501,032
505,564
496,063
524,881
496,023
256,277
299,963
294,460
214,940
233,533
233,533214,940294,460299,963256,277496,023524,881496,063505,564501,032584,540534,237539,592559,707590,233540,688566,669534,587464,991270,022
   > Total Current Liabilities 
254,377
236,492
274,750
303,114
271,050
318,144
281,034
255,805
247,875
295,665
209,277
206,970
195,250
219,814
186,918
211,320
256,575
249,721
168,870
188,677
188,677168,870249,721256,575211,320186,918219,814195,250206,970209,277295,665247,875255,805281,034318,144271,050303,114274,750236,492254,377
       Short-term Debt 
36,500
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000036,500
       Short Long Term Debt 
36,500
0
0
0
6,000
12,000
12,000
12,008
1,001
0
0
0
0
0
0
0
70,000
70,000
0
0
0070,00070,00000000001,00112,00812,00012,0006,00000036,500
       Accounts payable 
81,371
90,705
120,304
144,090
134,327
159,169
165,573
92,045
124,597
168,983
92,126
76,103
73,627
82,110
74,729
48,043
59,478
52,744
48,467
55,233
55,23348,46752,74459,47848,04374,72982,11073,62776,10392,126168,983124,59792,045165,573159,169134,327144,090120,30490,70581,371
       Other Current Liabilities 
0
0
147,022
129,646
121,565
130,518
94,695
130,067
112,158
106,478
108,312
103,799
111,286
124,114
101,660
1,628
119,545
112,494
112,662
1,836
1,836112,662112,494119,5451,628101,660124,114111,286103,799108,312106,478112,158130,06794,695130,518121,565129,646147,02200
   > Long-term Liabilities 
15,646
228,499
259,837
263,555
269,638
272,089
278,672
283,787
286,361
288,875
291,756
298,593
300,813
305,068
309,105
44,957
43,389
44,739
46,069
44,856
44,85646,06944,73943,38944,957309,105305,068300,813298,593291,756288,875286,361283,787278,672272,089269,638263,555259,837228,49915,646
       Capital Lease Obligations 
0
0
0
0
0
0
0
0
0
0
0
76
58
58
108
58
62
223
153
140
140153223625810858587600000000000
       Long-term Liabilities Other 
4,700
217,631
216,594
220,291
224,000
227,788
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000227,788224,000220,291216,594217,6314,700
       Deferred Long Term Liability 
8,061
15,019
15,417
17,069
17,400
19,079
21,552
22,407
23,560
27,352
33,026
24,889
29,525
30,835
32,877
0
0
47,341
51,972
0
051,97247,3410032,87730,83529,52524,88933,02627,35223,56022,40721,55219,07917,40017,06915,41715,0198,061
> Total Stockholder Equity
860,145
989,407
1,035,990
1,070,800
1,100,373
1,119,225
1,156,690
1,181,822
1,219,316
1,228,672
1,267,475
1,265,920
1,295,574
1,297,703
1,318,872
1,610,390
1,637,755
1,627,168
1,630,755
1,617,921
1,617,9211,630,7551,627,1681,637,7551,610,3901,318,8721,297,7031,295,5741,265,9201,267,4751,228,6721,219,3161,181,8221,156,6901,119,2251,100,3731,070,8001,035,990989,407860,145
   Common Stock
400,060
400,060
401,546
401,547
401,551
401,555
401,725
401,701
401,702
401,702
401,689
401,691
401,712
401,056
401,057
0
0
417,596
417,596
0
0417,596417,59600401,057401,056401,712401,691401,689401,702401,702401,701401,725401,555401,551401,547401,546400,060400,060
   Retained Earnings 
311,188
358,045
403,718
477,748
505,595
522,911
554,854
579,261
615,734
624,282
657,450
659,794
689,144
691,726
712,637
649,979
680,080
750,321
753,734
648,691
648,691753,734750,321680,080649,979712,637691,726689,144659,794657,450624,282615,734579,261554,854522,911505,595477,748403,718358,045311,188
   Capital Surplus 00000000000000000000
   Treasury Stock00000000000000000000
   Other Stockholders Equity 
0
82,404
82,357
82,297
82,295
82,316
82,306
81,972
81,998
81,927
81,942
81,866
81,745
81,948
82,171
0
-168
650
539
0
0539650-168082,17181,94881,74581,86681,94281,92781,99881,97282,30682,31682,29582,29782,35782,4040



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue691,543
Cost of Revenue-311,348
Gross Profit380,194380,194
 
Operating Income (+$)
Gross Profit380,194
Operating Expense-650,403
Operating Income41,139-270,209
 
Operating Expense (+$)
Research Development78,120
Selling General Administrative220,653
Selling And Marketing Expenses0
Operating Expense650,403298,772
 
Net Interest Income (+$)
Interest Income9,810
Interest Expense-945
Other Finance Cost-68
Net Interest Income8,797
 
Pretax Income (+$)
Operating Income41,139
Net Interest Income8,797
Other Non-Operating Income Expenses0
Income Before Tax (EBT)42,79741,139
EBIT - interestExpense = -945
32,699
33,645
Interest Expense945
Earnings Before Interest and Taxes (EBIT)043,742
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax42,797
Tax Provision-10,098
Net Income From Continuing Ops32,69932,699
Net Income32,699
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0-8,797
 

Technical Analysis of Pharscin
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Pharscin. The general trend of Pharscin is BEARISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Pharscin's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-42.9%) Bearish trend (42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Chongqing Pharscin Pharmaceutical Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 14.51 < 15.71 < 17.43.

The bearish price targets are: 12.21 > 10.66 > 9.82.

Tweet this
Chongqing Pharscin Pharmaceutical Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Chongqing Pharscin Pharmaceutical Co Ltd. The current mas is .

The long score for the Moving Averages is 4/14.
The longshort score for the Moving Averages is -6/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Chongqing Pharscin Pharmaceutical Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Chongqing Pharscin Pharmaceutical Co Ltd. The current macd is -0.0927101.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Pharscin price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Pharscin. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Pharscin price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Chongqing Pharscin Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartChongqing Pharscin Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Chongqing Pharscin Pharmaceutical Co Ltd. The current adx is 19.30.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Pharscin shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
Chongqing Pharscin Pharmaceutical Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Chongqing Pharscin Pharmaceutical Co Ltd. The current sar is 12.36.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Chongqing Pharscin Pharmaceutical Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Chongqing Pharscin Pharmaceutical Co Ltd. The current rsi is 59.76. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending up: The RSI is trending up. +1
Chongqing Pharscin Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) ChartChongqing Pharscin Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Chongqing Pharscin Pharmaceutical Co Ltd. The current phase is Overbought in bear market.

The long score for the Stochastic Oscillator is 6/6.
The longshort score for the Stochastic Oscillator is 6/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Pharscin price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Chongqing Pharscin Pharmaceutical Co Ltd Daily Stochastic Oscillator ChartChongqing Pharscin Pharmaceutical Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Chongqing Pharscin Pharmaceutical Co Ltd. The current cci is 113.29.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Chongqing Pharscin Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) ChartChongqing Pharscin Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Chongqing Pharscin Pharmaceutical Co Ltd. The current cmo is 35.79.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Chongqing Pharscin Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) ChartChongqing Pharscin Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Chongqing Pharscin Pharmaceutical Co Ltd. The current willr is -2.62008734.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Chongqing Pharscin Pharmaceutical Co Ltd Daily Williams %R ChartChongqing Pharscin Pharmaceutical Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Chongqing Pharscin Pharmaceutical Co Ltd.

Chongqing Pharscin Pharmaceutical Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Chongqing Pharscin Pharmaceutical Co Ltd. The current atr is 0.53883375.

Chongqing Pharscin Pharmaceutical Co Ltd Daily Average True Range (ATR) ChartChongqing Pharscin Pharmaceutical Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Chongqing Pharscin Pharmaceutical Co Ltd. The current obv is 318,683,370.

Chongqing Pharscin Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) ChartChongqing Pharscin Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Chongqing Pharscin Pharmaceutical Co Ltd. The current mfi is 62.36.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Chongqing Pharscin Pharmaceutical Co Ltd Daily Money Flow Index (MFI) ChartChongqing Pharscin Pharmaceutical Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Chongqing Pharscin Pharmaceutical Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-01WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-04STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-05DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-12-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-08STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2023-12-20STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-29SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-03DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-08ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-10SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-12CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-16STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-17WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-29CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-30BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-31ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-08RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-02-19SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-23WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-29CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-07CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-08STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-11CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-12STOCH LONG EXITThe %K line crosses below the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-20STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-21MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-25CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-28WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-08STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-10SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-11SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-04-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-16STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-25DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-04-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-04-29CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-30CCI LONG ENTRY SHORT CLOSE100 crossover to upside

6.3. Candlestick Patterns

Chongqing Pharscin Pharmaceutical Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Chongqing Pharscin Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5059.762
Ma 20Greater thanMa 5013.504
Ma 50Greater thanMa 10013.919
Ma 100Greater thanMa 20014.510
OpenGreater thanClose14.240
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Pharscin with someone you think should read this too:
  • Are you bullish or bearish on Pharscin? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Pharscin? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Chongqing Pharscin Pharmaceutical Co Ltd

I send you an email if I find something interesting about Chongqing Pharscin Pharmaceutical Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Chongqing Pharscin Pharmaceutical Co Ltd.

Receive notifications about Chongqing Pharscin Pharmaceutical Co Ltd in your mailbox!